Precision Business Insights
Portfolio

 

Spider Venom Market

: Global Market Estimation, Dynamics, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025

Global Spider Venom Market: By Product Type (Monovalent, Polyvalent), By Application (Neurotoxic, Cytotoxic, Cardiotoxic, Haemotoxic, Others), By End User (Hospitals, Clinics, Others), and Geography

 

Global Spider Venom Market

 

Market Outline: Global Spider Venom Market

Spider are the venomous animals with an estimated of approximately 100,000 extant species. Spider venoms are complex cocktails composed of various compounds such as salts, peptides, small organic molecules, and proteins. Peptides are the primary components of spider venoms, and some species produce venom containing >1000 unique peptides of mass 2–8 kDa.

 

Market Dynamics: Global Spider Venom Market

The well-known neurotoxic effects of spider venom, they contain peptides with antimicrobial, antiarrhythmic, antparasitic, cytotoxic, analgesic, and hemolytic activity drives the global spider venom market. Moreover, rise in funding for the R&D activities from public and private sectors, large patient pool, unmet medical needs, grow in awareness about the antivenoms, and wide range of therapeutic applications with spider venoms are anticipated to surge the global spider venoms market over the forecast years. However, stringent regulatory guidelines, high manufacturing cost, quality standards, and inefficient production process are hinder the growth of global spider venoms market.

 

Market Scope: Global Spider Venom Market

Global spider venom market is segmented based on product type, application, and end user

Based on product type, market is segmented into the following:

  • Monovalent
  • Polyvalent

Based on the application, market is segmented into the following:

  • Neurotoxic
  • Cytotoxic
  • Cardiotoxic
  • Haemotoxic
  • Others

Based on the end users, the market is segmented into the following:

  • Hospitals
  • Clinics
  • Others

Geography

North America

  • US
  • Canada

Europe

  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Poland
  • Rest of Europe

Asia-Pacific

  • Japan
  • China
  • India
  • Australia & New Zealand
  • ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
  • South Korea
  • Rest of Asia-Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Venezuela
  • Rest of Latin America

Middle East and Africa (MEA)

  • Gulf Cooperation Council (GCC) Countries
  • Israel
  • South Africa
  • Rest of MEA

Regional Analysis: Global Spider Venom Market

Geographically, global spider venom market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America spider venom market is poised to grow due to rise in adoption of antivenom treatment procedures, increase in the prevalence of neurological and cardiovascular disorders, and grow in healthcare expenditure are impel the market. Europe spider venom market is driving by rise in adoption of newer spider venom and procedures, presence of skilled professionals in developed countries, and increase in prevalence of lifestyle disorders such as obesity and diabetes couple with rise in number of cardiac and gynecological surgical procedures are surge the market. Asia Pacific spider venom market has prominent share attributed to increase in the medical tourism in Asia Pacific countries, rise in disposable income, and large patient pool in Asia Pacific region are fuel the market.

 

Competition Assessment: Global Spider Venom Market

Some of the players in the global spider venom market include:

  • CSL Behring (Australia)
  • Bharat Serums and Vaccines Limited (India)
  • Haffkine Bio-Pharmaceutical Corporation Ltd.  (India)
  • Vacsera C0. (Egypt)
  • VINS BioProducts Limited (India)
  • Rare Disease Therapeutics, Inc.  (U.S.)